Pathstone Holdings’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.42M Buy
5,201
+1,279
+33% +$538K 0.01% 999
2026
Q1
$1.48M Buy
3,922
+1,222
+45% +$523K 0.01% 1203
2025
Q4
$1.16M Sell
2,700
-1,019
-27% -$444K ﹤0.01% 1323
2025
Q3
$1.67M Sell
3,719
-601
-14% -$272K 0.01% 1138
2025
Q2
$2.1M Buy
4,320
+460
+12% +$262K 0.01% 965
2025
Q1
$2.37M Buy
3,860
+49
+1% +$27.9K 0.01% 883
2024
Q4
$2.02M Buy
3,811
+117
+3% +$66K 0.01% 969
2024
Q3
$2.22M Buy
3,694
+210
+6% +$119K 0.01% 910
2024
Q2
$1.89M Sell
3,484
-30
-0.9% -$17.2K 0.01% 950
2024
Q1
$2.26M Buy
3,514
+97
+3% +$58.9K 0.01% 846
2023
Q4
$2M Buy
+3,417
New +$1.91M 0.01% 740

Other funds holding CHE

Pathstone Holdings's CHE Position: Q2 2026 in Review

Pathstone Holdings increased its Chemed (CHE) stake by 33% in Q2 2026, buying an estimated $538K and bringing the position to 5,201 shares worth $2.42M. The position accounts for 0.01% of the portfolio, ranked #999.

Pathstone Holdings first reported a position in CHE in Q4 2023 and has held it in 11 quarters since. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Pathstone Holdings held 5,201 shares of Chemed worth $2.42M as of Q2 2026.
  • Pathstone Holdings bought 1,279 Chemed shares in Q2 2026, an estimated $538K.
  • Chemed made up 0.01% of Pathstone Holdings's portfolio in Q2 2026, its #999 holding.
  • Pathstone Holdings first reported a position in Chemed in Q4 2023 and has held it in 11 quarters since.
  • 530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.